W World Corp. (WWHC)

[OTCRIDER]

Pharmos Corporation (Pharmos) is a biopharmaceutical company that discovers and develops therapeutics to treat a range of metabolic and nervous system disorders, including gout, disorders of the brain-gut axis, pain/inflammation and autoimmune disorders. Pharmos owns the rights to both R and S Tofisopam. These are the two enantiomers of racemic tofisopam that has been used outside the United States. The Company's primary focus is on the development and partnering of Levotofisopam and Dextofisopam. The Company's product Dextofisopam is used for the treatment of irritable bowel syndrome (IBS). Dextofisopam is the R enantiomer of racemic tofisopam. Levotofisopam is the S-enantiomer of the racemic mixture RS-tofisopam.



http://pharmoscorp.com/

Headquarters: SUITE 301, 99 WOOD AVE. SOUTH
ISELIN, NJ 08830

ABOVE INFO FROM ETRADE...